FDA Drug recall D-0879-2023
Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufact…
- FDA Drug
- Class II
- terminated
- Published 2023-07-05
On 2023-07-05 the FDA classified a Class II recall of Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufact… by Ferring Pharmaceuticals, citing cGMP deviations: potential for Microbial Contamination of Non-Sterile Products.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0879-2023 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2023-06-12 |
| Published | 2023-07-05 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Ferring Pharmaceuticals |
| Distribution | US |
Product
Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufactured for: Ferring Pharmaceuticals Inc., Parsippany, NJ NDC# 55566-6500-03
Reason
cGMP deviations: potential for Microbial Contamination of Non-Sterile Products
Identifiers
| code_info | AA200A, AA201A, Exp. 12/2025 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0879-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.